Comparison of protein expression by isotope-coded affinity tag labeling.

Area of Science:

• Proteomics
• Cancer Biology
• Biochemistry

Background:

• Isotope-coded affinity tag (ICAT) labeling coupled with mass spectrometry (MS) is a key technique for quantitative proteomic analysis.
• Celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, is investigated for its role in colorectal cancer prevention.
• Understanding proteomic alterations in cancer cells treated with celecoxib is crucial for cancer research.

Purpose of the Study:

• To describe the ICAT labeling procedure for identifying celecoxib-regulated proteins in a colon cancer cell line (HT-29).
• To elucidate proteomic changes induced by celecoxib, a COX-2 specific inhibitor.
• To highlight the critical role of sample preparation in ICAT-based protein expression studies.

Main Methods:

• Utilized ICAT labeling to differentiate and quantify proteins in celecoxib-treated and control colon cancer cells.
• Cysteine-containing proteins were labeled with heavy and light ICAT reagents.
• Purification of ICAT-labeled peptides involved an avidin column and biotin tag cleavage.

Main Results:

• The study focuses on the ICAT labeling methodology as the primary experimental step.
• Successful application of ICAT labeling to prepare samples for proteomic comparison.
• The procedure is foundational for identifying changes in protein expression.

Conclusions:

• ICAT labeling is an effective method for comparative proteomic studies, particularly for analyzing drug-induced changes.
• Accurate sample preparation, including ICAT labeling, is paramount for reliable proteomic data.
• This methodology facilitates the discovery of proteins affected by celecoxib in colon cancer cells.